3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
57
Pancreatic Neoplasms
39
Carcinoma, Non-Small-Cell Lung
29
Triple Negative Breast Neoplasms
20
Neoplasms
17
Neoplasm Metastasis
11
Lung Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
9
Ovarian Neoplasms
8
Melanoma
7
Head and Neck Neoplasms
6
Breast Neoplasms, Male
6
Adenocarcinoma
6
Urinary Bladder Neoplasms
5
Inflammatory Breast Neoplasms
5
Carcinoma
5
Sarcoma
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Pancreatic Diseases
4
Fallopian Tube Neoplasms
4
Cholangiocarcinoma
4
Carcinoma, Ovarian Epithelial
4
Stomach Neoplasms
3
Small Cell Lung Carcinoma
3
Pancreatic Adenocarcinoma
3
Esophageal Neoplasms
3
Endocrine System Diseases
3
Endocrine Gland Neoplasms
3
Digestive System Neoplasms
3
Digestive System Diseases
3
Interventions
Gemcitabine
5
Paclitaxel
4
Nivolumab
3
cobimetinib
2
atezolizumab
2
adavosertib
2
Ramucirumab
2
N-((5-bromo-2-thienyl)sulfonyl)-2,4-dichlorobenzamide
2
Carboplatin
2
zansecimab
1
tocilizumab
1
tivozanib
1
tislelizumab
1
temsirolimus
1
ridaforolimus
1
plocabulin
1
pexidartinib
1
pevonedistat
1
pembrolizumab
1
pamiparib
1
obinutuzumab
1
necitumumab
1
liposomal doxorubicin
1
lenvatinib
1
glasdegib
1
futuximab
1
demplatin pegraglumer
1
birinapant
1
avelumab
1
Temozolomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Solid Tumors
×
Albumin-Bound Paclitaxel
×
Clear all
No trials found.